ALK-IN-29 (compound 4c) has a certain inhibitory effect on tyrosine protein kinases ALK, CDK2/CyclinE1 and FAK, among which the strongest inhibitory effect on ALK kinase is 40.63% at a concentration of 10 µM. ALK-IN-29 can be used for anti-cancer research[1].
Molekulargewicht:
457.58
Formel:
C29H32FN3O
Target-Kategorie:
Anaplastic lymphoma kinase (ALK),CDK,FAK
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
